Hyperoxia-derived lung damage in preterm infants
Tóm tắt
Từ khóa
Tài liệu tham khảo
Warner, 1998, Functional and pathological effects of prolonged hyperoxia in neonatal mice, Am J Physiol, 275, L110
O’Reilly, 2001, DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair, Am J Physiol Lung Cell Mol Physiol, 281, L291, 10.1152/ajplung.2001.281.2.L291
Thickett, 2001, Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome, Am J Respir Crit Care Med, 164, 1601, 10.1164/ajrccm.164.9.2011071
Crapo, 1986, Morphologic changes in pulmonary oxygen toxicity, Annu Rev Physiol, 48, 721, 10.1146/annurev.ph.48.030186.003445
Ben-Ari, 2000, Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats, Isr Med Assoc J, 2, 365
O’Reilly, 2008, Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus, Am J Respir Crit Care Med, 177, 1103, 10.1164/rccm.200712-1839OC
Yee, 2009, Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity, Am J Physiol Lung Cell Mol Physiol, 297, L641, 10.1152/ajplung.00023.2009
Johnston, 1997, Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia, Exp Lung Res, 23, 537, 10.3109/01902149709039242
Frank, 1991, Developmental aspects of experimental pulmonary oxygen toxicity, Free Radic Biol Med, 11, 463, 10.1016/0891-5849(91)90062-8
Coalson, 1999, Neonatal chronic lung disease in extremely immature baboons, Am J Respir Crit Care Med, 160, 1333, 10.1164/ajrccm.160.4.9810071
Bhandari, 2006, Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung, Free Radic Biol Med, 41, 4, 10.1016/j.freeradbiomed.2006.01.027
Barazzone, 2000, Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins, Am J Respir Cell Mol Biol, 22, 517, 10.1165/ajrcmb.22.5.f180
Pagano, 2003, Alveolar cell death in hyperoxia-induced lung injury, Ann NY Acad Sci, 1010, 405, 10.1196/annals.1299.074
Bustani, 2003, Role of cytokines in hyperoxia mediated inflammation in the developing lung, Front Biosci, 8, s694, 10.2741/1113
Mantell, 1999, Hyperoxia-induced cell death in the lung – the correlation of apoptosis, necrosis, and inflammation, Ann NY Acad Sci, 887, 171, 10.1111/j.1749-6632.1999.tb07931.x
Thiel, 2005, Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury, PLoS Biol, 3, e174, 10.1371/journal.pbio.0030174
Vozzelli, 2004, Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung, Am J Physiol Lung Cell Mol Physiol, 286, L488, 10.1152/ajplung.00414.2002
Boyce, 1989, Granulocyte independence of pulmonary oxygen toxicity in the rat, Exp Lung Res, 15, 491, 10.3109/01902148909087873
Kroemer, 1995, The biochemistry of programmed cell death, Faseb J, 9, 1277, 10.1096/fasebj.9.13.7557017
Ward, 2000, Interleukin-6-induced protection in hyperoxic acute lung injury, Am J Respir Cell Mol Biol, 22, 535, 10.1165/ajrcmb.22.5.3808
Joza, 2002, Genetic analysis of the mammalian cell death machinery, Trends Genet, 18, 142, 10.1016/S0168-9525(01)02618-X
O’Reilly, 2000, Bcl-2 family gene expression during severe hyperoxia induced lung injury, Lab Invest, 80, 1845, 10.1038/labinvest.3780195
Wang, 2003, Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway, J Biol Chem, 278, 29184, 10.1074/jbc.M301624200
Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat Immunol, 6, 1191, 10.1038/ni1276
Thomson, 2008, Pulmonary biomarkers of bronchopulmonary dysplasia, Biomarker Insights, 3, 361
Bhandari, 2009, Pitfalls, problems, and progress in bronchopulmonary dysplasia, Pediatrics, 123, 1562, 10.1542/peds.2008-1962
Subramaniam, 2007, Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia, Am J Respir Crit Care Med, 176, 902, 10.1164/rccm.200611-1734OC
Sunday, 1998, Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia, J Clin Invest, 102, 584, 10.1172/JCI2329
Cullen, 2002, Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia, Am J Respir Crit Care Med, 165, 1093, 10.1164/ajrccm.165.8.2108044
Padela, 2005, Hepatocyte growth factor is required for alveologenesis in the neonatal rat, Am J Respir Crit Care Med, 172, 907, 10.1164/rccm.200504-567OC
Ohki, 2009, Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia, Neonatology, 95, 332, 10.1159/000187651
Lassus, 2003, Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants, J Pediatr, 143, 199, 10.1067/S0022-3476(03)00297-X
D’Angio, 1999, Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit, Exp Lung Res, 25, 443, 10.1080/019021499270187
Bry, 2007, IL-1beta disrupts postnatal lung morphogenesis in the mouse, Am J Respir Cell Mol Biol, 36, 32, 10.1165/rcmb.2006-0116OC
Choo-Wing, 2007, Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia, Am J Physiol Lung Cell Mol Physiol, 293, L142, 10.1152/ajplung.00434.2006
Lindsay, 2000, Modulation of hyperoxia-induced TNF-alpha expression in the newborn rat lung by thalidomide and dexamethasone, Inflammation, 24, 347, 10.1023/A:1007096931078
Wagenaar, 2004, Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress, Free Radic Biol Med, 36, 782, 10.1016/j.freeradbiomed.2003.12.007
Deng, 2000, Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats, Am J Respir Crit Care Med, 162, 2316, 10.1164/ajrccm.162.6.9911020
Auten, 2001, Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats, Am J Physiol Lung Cell Mol Physiol, 281, L336, 10.1152/ajplung.2001.281.2.L336
Frank, 2003, Protective effect of keratinocyte growth factor against lung abnormahlities associated with hyperoxia in prematurely born rats, Biol Neonate, 83, 263, 10.1159/000069480
Franco-Montoya, 2009, Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia, Am J Physiol Lung Cell Mol Physiol, 297, L965, 10.1152/ajplung.00136.2009
Danan, 2002, High concentrations of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia, Am J Respir Crit Care Med, 165, 1384, 10.1164/rccm.200112-134BC
Baier, 2004, CC chemokine concentrations, increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia, Pediatr Pulmonol, 37, 137, 10.1002/ppul.10417
Radomski, 1998, The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats, Br J Pharmacol, 125, 1455, 10.1038/sj.bjp.0702216
Hosford, 2004, Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization, Pediatr Res, 56, 26, 10.1203/01.PDR.0000130658.45564.1F
Tambunting, 2005, Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia, Pediatr Pulmonol, 39, 5, 10.1002/ppul.20135
Chetty, 2008, Role of matrix metalloprotease-9 in hyperoxic injury in developing lung, Am J Physiol Lung Cell Mol Physiol, 295, L584, 10.1152/ajplung.00441.2007
Lukkarinen, 2009, Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia, Am J Respir Cell Mol Biol, 41, 59, 10.1165/rcmb.2008-0179OC
Cederqvist, 2001, Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress, Pediatrics, 108, 686, 10.1542/peds.108.3.686
Sweet, 2004, The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease, Acta Paediatr, 93, 791, 10.1111/j.1651-2227.2004.tb03020.x
Dasgupta, 2009, Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone, Am J Physiol Lung Cell Mol Physiol, 296, L1031, 10.1152/ajplung.90392.2008
Alejandre-Alcazar, 2007, Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia, Am J Physiol Lung Cell Mol Physiol, 292, L537, 10.1152/ajplung.00050.2006
Nakanishi, 2007, TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung, Am J Physiol Lung Cell Mol Physiol, 293, L151, 10.1152/ajplung.00389.2006
Gauldie, 2003, Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia, Am J Pathol, 163, 2575, 10.1016/S0002-9440(10)63612-7
Vicencio, 2004, Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?, Am J Respir Cell Mol Biol, 31, 650, 10.1165/rcmb.2004-0092OC
D’Angio, 2002, The role of vascular growth factors in hyperoxia-induced injury to the developing lung, Front Biosci, 7, d1609, 10.2741/angio
Bhandari, 2008, Developmental regulation of NO-mediated VEGF-induced effects in the lung, Am J Respir Cell Mol Biol, 39, 420, 10.1165/rcmb.2007-0024OC